Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy

M. G. Vossen; L. Ehmann; S. Pferschy; A. Maier-Salamon; M. Haidinger; C. Weiser; J. M. Wenisch; K. Saria; C. Kajahn; S. Jilch; R. Lemmerer; M. Bécède; M. Zeitlinger; C. Kloft; W. Jäger; F. Thalhammera

doi:10.1128/AAC.02430-17

Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy

M. G. Vossen, L. Ehmann, S. Pferschy, A. Maier-Salamon, M. Haidinger, C. Weiser, J. M. Wenisch, K. Saria, C. Kajahn, S. Jilch, R. Lemmerer, M. Bécède, M. Zeitlinger, C. Kloft, W. Jäger, F. Thalhammera

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Article number	e02430-17
Number of pages	9
Journal	Antimicrobial Agents and Chemotherapy
Volume	62
Issue number	5
DOIs	https://doi.org/10.1128/AAC.02430-17
Publication status	Published - 1 May 2018

Austrian Fields of Science 2012

301207 Pharmaceutical chemistry

Keywords

Anti-infective agents
Hemodialysis
Intermittent renal replacement therapy
Pharmacokinetics
Population pharmacokinetics
HIGH-FLUX MEMBRANES
LONG-TERM HEMODIALYSIS
population pharmacokinetics
MEROPENEM
MULTIPLE-DOSE PHARMACOKINETICS
CEFEPIME
anti-infective agents
pharmacokinetics
hemodialysis
CRITICALLY-ILL PATIENTS
intermittent renal replacement therapy
HEMODIAFILTRATION

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/AAC.02430-17

Cite this

Vossen, M. G., Ehmann, L., Pferschy, S., Maier-Salamon, A., Haidinger, M., Weiser, C., Wenisch, J. M., Saria, K., Kajahn, C., Jilch, S., Lemmerer, R., Bécède, M., Zeitlinger, M., Kloft, C., Jäger, W., & Thalhammera, F. (2018). Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy. Antimicrobial Agents and Chemotherapy, 62(5), Article e02430-17. https://doi.org/10.1128/AAC.02430-17

@article{a7e2fc19e1034ef78403e602e8066858,

title = "Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy",

keywords = "Anti-infective agents, Hemodialysis, Intermittent renal replacement therapy, Pharmacokinetics, Population pharmacokinetics, HIGH-FLUX MEMBRANES, LONG-TERM HEMODIALYSIS, population pharmacokinetics, MEROPENEM, MULTIPLE-DOSE PHARMACOKINETICS, CEFEPIME, anti-infective agents, pharmacokinetics, hemodialysis, CRITICALLY-ILL PATIENTS, intermittent renal replacement therapy, HEMODIAFILTRATION",

author = "Vossen, {M. G.} and L. Ehmann and S. Pferschy and A. Maier-Salamon and M. Haidinger and C. Weiser and Wenisch, {J. M.} and K. Saria and C. Kajahn and S. Jilch and R. Lemmerer and M. B{\'e}c{\`e}de and M. Zeitlinger and C. Kloft and W. J{\"a}ger and F. Thalhammera",

year = "2018",

month = may,

day = "1",

doi = "10.1128/AAC.02430-17",

language = "English",

volume = "62",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "AMER SOC MICROBIOLOGY",

number = "5",

}

Vossen, MG, Ehmann, L, Pferschy, S, Maier-Salamon, A, Haidinger, M, Weiser, C, Wenisch, JM, Saria, K, Kajahn, C, Jilch, S, Lemmerer, R, Bécède, M, Zeitlinger, M, Kloft, C, Jäger, W & Thalhammera, F 2018, 'Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy', Antimicrobial Agents and Chemotherapy, vol. 62, no. 5, e02430-17. https://doi.org/10.1128/AAC.02430-17

TY - JOUR

T1 - Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy

AU - Vossen, M. G.

AU - Ehmann, L.

AU - Pferschy, S.

AU - Maier-Salamon, A.

AU - Haidinger, M.

AU - Weiser, C.

AU - Wenisch, J. M.

AU - Saria, K.

AU - Kajahn, C.

AU - Jilch, S.

AU - Lemmerer, R.

AU - Bécède, M.

AU - Zeitlinger, M.

AU - Kloft, C.

AU - Jäger, W.

AU - Thalhammera, F.

PY - 2018/5/1

Y1 - 2018/5/1

KW - Anti-infective agents

KW - Hemodialysis

KW - Intermittent renal replacement therapy

KW - Pharmacokinetics

KW - Population pharmacokinetics

KW - HIGH-FLUX MEMBRANES

KW - LONG-TERM HEMODIALYSIS

KW - population pharmacokinetics

KW - MEROPENEM

KW - MULTIPLE-DOSE PHARMACOKINETICS

KW - CEFEPIME

KW - anti-infective agents

KW - pharmacokinetics

KW - hemodialysis

KW - CRITICALLY-ILL PATIENTS

KW - intermittent renal replacement therapy

KW - HEMODIAFILTRATION

UR - http://www.scopus.com/inward/record.url?scp=85046024064&partnerID=8YFLogxK

U2 - 10.1128/AAC.02430-17

DO - 10.1128/AAC.02430-17

M3 - Article

AN - SCOPUS:85046024064

SN - 0066-4804

VL - 62

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 5

M1 - e02430-17

ER -

Elimination of doripenem during dialysis and pharmacokinetic evaluation of posthemodialysis dosing for patients undergoing intermittent renal replacement therapy

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Cite this